or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    LLY F -1.03 10.15
    BSX A 1.48 7.57
    ISRG A 1.33 5.94
    UNH B -0.13 5.35
    ABBV F 1.78 5.21
    PODD B -0.55 4.90
    AMGN D 0.03 4.08
    ABT B 0.24 4.06
    MRK F 1.11 4.00
    DHR D -0.62 3.47
    BMRN F 0.05 2.64
    VEEV C 1.43 2.06
    ARGX A 0.19 2.05
    NBIX C 1.35 1.76
    ALNY D 0.28 1.55
    IDXX F -1.24 1.53
    WST C 0.84 1.27
    MTD F 0.00 1.24
    NTRA A 0.93 0.91
    MDGL C 1.16 0.70
    CGON F -0.59 0.65
    RARE F 0.58 0.63
    PCVX D 1.60 0.60
    ALGN D 0.93 0.59
    ROIV D 3.35 0.59
    GMAB F 0.02 0.55
    BPMC C 1.10 0.53
    XENE D 1.65 0.46
    TMDX F 3.56 0.45
    IRTC C 0.41 0.35
    ANAB F 2.46 0.20

    Represented by ETF Holdings

    Keywords: S&P 500 Medicine Biopharmaceutical Biotechnology Cancer Life Sciences Diabetes Inflammation Autoimmune Disease Glucose Nasdaq 100 Pharmaceutical Products Acid Amyloid Antibiotics Antibodies Cholesterol Clinical Medicine Disease Dow Jones Component
    Industries: Biotechnology Medical Devices Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies Health Care Plans Health Information Services Long-Term Care Facilities

    Recent News for Goldman Sachs Future Health Care Equity ETF & its Holdings

    Date Stock Title
    Nov 21 ABT Major companies that are also popular short-selling stocks
    Nov 21 IDXX IDEXX Laboratories CFO Brian McKeon to step down
    Nov 21 IDXX IDEXX Announces CFO Transition
    Nov 21 VEEV Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
    Nov 21 AMGN Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
    Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
    Nov 21 UNH 3 Dividend Growth Stocks That Have Increased Their Payouts by More Than 90% in 5 Years
    Nov 21 AMGN Amgen picks prolific biotech founder Chang as new top scientist
    Nov 21 VEEV Veeva on supporting the data burden in the life sciences sector
    Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 AMGN Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 20 PODD Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
    Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
    Nov 20 IRTC iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
    Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
    Nov 20 ALGN Align Technology Has Received CE Mark in Europe for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients
    Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
    Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
    Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
    Nov 20 MDGL Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra
    Goldman Sachs Future Health Care Equity ETF is an exchange traded fund launched and managed by Goldman Sachs Asset Management, L.P. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating across health care including genomics, precision medicine, technology-enabled procedures, and digital healthcare sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund employs fundamental analysis and quantitative with to create its portfolio. It seeks to benchmark the performance of its portfolio against the MSCI ACWI Health Care Index. The fund employs proprietary research to create its portfolio. Goldman Sachs Future Health Care Equity ETF was formed on November 9, 2021 and is domiciled in the United States.
    Exchange Traded Funds SPDR Synthetic Replication Genomics Goldman Sachs
    Back to the Main GDOC Page...